News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
8,712 Results
Type
Article (1314)
Company Profile (1)
Press Release (7397)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (2059)
Career Advice (341)
Deals (356)
Drug Delivery (2)
Drug Development (650)
Employer Resources (16)
FDA (256)
Job Trends (251)
News (3687)
Policy (460)
Tag
Academia (81)
Allergies (1)
Alliances (443)
Alzheimer's disease (27)
Approvals (249)
Artificial intelligence (12)
Autoimmune disease (1)
Bankruptcy (2)
Best Places to Work (176)
Bladder cancer (4)
Brain cancer (3)
Breast cancer (2)
Cancer (32)
Cardiovascular disease (2)
Career advice (282)
Career pathing (1)
CAR-T (2)
Cell therapy (8)
Clinical research (509)
Collaboration (17)
Compensation (1)
COVID-19 (52)
C-suite (12)
Data (36)
Denatured (3)
Depression (3)
Diabetes (2)
Diagnostics (65)
Diversity, equity & inclusion (4)
Drug discovery (3)
Drug pricing (3)
Duchenne muscular dystrophy (1)
Earnings (622)
Editorial (1)
Employer branding (1)
Employer resources (13)
Events (733)
Executive appointments (6)
FDA (284)
Funding (16)
Gene editing (1)
Generative AI (3)
Gene therapy (20)
GLP-1 (14)
Government (98)
Guidances (4)
Healthcare (284)
Huntington's disease (1)
Immunology and inflammation (2)
Immuno-oncology (1)
Infectious disease (52)
Inflammatory bowel disease (1)
Interviews (87)
IPO (145)
IRA (2)
Job creations (69)
Job search strategy (224)
JPM (5)
Labor market (2)
Layoffs (11)
Leadership (6)
Legal (93)
Liver cancer (3)
Lung cancer (1)
Lymphoma (2)
Management (5)
Manufacturing (9)
MASH (4)
Medical device (303)
Medtech (303)
Mergers & acquisitions (215)
Metabolic disorders (15)
Multiple sclerosis (1)
Neurodegenerative disease (3)
Neuropsychiatric disorders (3)
Neuroscience (38)
NextGen: Class of 2026 (153)
Non-profit (105)
Obesity (9)
Opinion (41)
Ovarian cancer (4)
Pain (2)
Parkinson's disease (1)
Patents (3)
Patient recruitment (4)
People (750)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (115)
Phase 2 (233)
Phase 3 (206)
Pipeline (41)
Policy (12)
Postmarket research (35)
Preclinical (56)
Prostate cancer (2)
Psychedelics (2)
Radiopharmaceuticals (4)
Rare diseases (3)
Real estate (86)
Recruiting (9)
Regulatory (307)
Reports (1)
Research institute (49)
Resumes & cover letters (50)
Schizophrenia (3)
Series A (2)
Series B (1)
Spinal muscular atrophy (1)
Sponsored (2)
Startups (64)
Supply chain (2)
Tariffs (2)
The Weekly (1)
Vaccines (9)
Venture capital (5)
Weight loss (6)
Women's health (1)
Worklife (1)
Date
Last 7 days (7)
Last 30 days (26)
Last 365 days (304)
2026 (32)
2025 (291)
2024 (264)
2023 (324)
2022 (587)
2021 (617)
2020 (681)
2019 (778)
2018 (611)
2017 (487)
2016 (492)
2015 (499)
2014 (417)
2013 (332)
2012 (372)
2011 (407)
2010 (332)
Location
Africa (71)
Alaska (1)
Arizona (7)
Asia (436)
Australia (139)
California (58)
Canada (65)
China (4)
Colorado (2)
Delaware (6)
Europe (1149)
Florida (9)
Idaho (2)
Illinois (13)
India (1)
Japan (2)
Maryland (8)
Massachusetts (33)
Michigan (37)
Minnesota (24)
Missouri (4)
New Jersey (12)
New York (31)
North Carolina (5)
Northern California (28)
Ohio (2)
Oregon (3)
Pennsylvania (10)
Puerto Rico (1)
South America (103)
Southern California (22)
Tennessee (1)
Texas (10)
United States (290)
Utah (3)
Virginia (5)
Washington D.C. (1)
Washington State (10)
8,712 Results for "sound pharmaceuticals.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Insights
From Sound Bites to Signals: Editors Parse Executive and Investor Chatter at JPM
In this episode of Denatured, BioSpace editorial team members, Senior Editor, Annalee Armstrong, and News Editor, Dan Samorodnitsky, discuss their post-JPM takeaways and 2026 forecasts after speaking to a range of pharma and biotech executives and investors last week.
January 22, 2026
·
1 min read
·
Jennifer Smith-Parker
Press Releases
Sound Pharmaceuticals Receives FDA Breakthrough Therapy Designation for SPI-1005 to Treat Meniere’s Disease
December 2, 2025
·
3 min read
Press Releases
BOOST Pharma Adds Sound Bioventures to Investor Syndicate with SEK 34 Million Investment to Advance Stem Cell Therapy for Osteogenesis Imperfecta
November 3, 2025
·
2 min read
Press Releases
Sound Pharma to Present at Upcoming Life Sciences Industry Conferences
July 9, 2025
·
2 min read
Press Releases
Sound Blade Medical Appoints Neil Barman, M.D. as Chief Executive Officer
August 1, 2025
·
2 min read
Government
100+ CEOs, Biopharma Leaders Sound Alarm on ‘Catastrophic’ Health Cuts
In an open letter addressing the Trump administration’s proposed budget cuts to HHS, the executives urged Congress to continue “robust federal funding” for scientific research, which they say will help maintain U.S. biotech leadership globally.
June 30, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Sound Pharma to Present at Upcoming Life Science Investor Conferences
April 8, 2025
·
2 min read
Job Trends
Sounding Off: Political Climate, Job Market Have Some Eyeing Biopharma Work Abroad
Nearly a third of employed and almost half of unemployed
BioSpace
survey respondents are seriously considering leaving the U.S. to find biotech and pharma jobs. Concerns about how the political climate is affecting biopharma are a key driver for many.
May 29, 2025
·
5 min read
·
Angela Gabriel
BioForest
Sound Pharmaceuticals’ IND Involving Cochlear Implantation Allowed by the FDA
Sound Pharmaceuticals (SPI) is pleased to announce that it has received FDA notification that its Investigational New Drug Application (IND) may proceed involving SPI-1005 treatment and cochlear implantation (CI).
May 20, 2024
·
3 min read
Regulatory
Former FDA Officials Sound Alarm: Visible Changes May Be ‘Tip of the Iceberg’
In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER director spoke to analysts about potential implications for drug review timelines and agency morale.
April 16, 2025
·
3 min read
·
Heather McKenzie
1 of 872
Next
